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Abstract
Nonsyndromic orofacial clefts (OFCs) are a heterogeneous group of common craniofacial birth 
defects with complex etiologies that include genetic and environmental risk factors. OFCs are 
commonly categorized as cleft lip with or without cleft palate (CL/P) and cleft palate alone (CP), 
which have historically been analyzed as distinct entities. Genes for both CL/P and CP have been 
identified via multiple genome-wide linkage and association studies (GWAS), however, altogether, 
known variants account for a minority of the estimated heritability in risk to these craniofacial 
birth defects. We performed genome-wide meta-analyses of CL/P, CP, and all OFCs across two 
large, multiethnic studies. We then performed population specific meta-analyses in sub-samples of 
Asian and European ancestry. In addition to observing associations with known variants, we 
identified a novel genome-wide significant association between SNPs located in an intronic TP63 
enhancer and CL/P (p = 1.16 × 10−8). Several novel loci with compelling candidate genes 
approached genome-wide significance on 4q21.1 (SHROOM3), 12q13.13 (KRT18), and 8p21 
(NRG1). In the analysis of all OFCs combined, SNPs near FOXE1 reached genome-wide 
significance (p = 1.33 × 10−9). Our results support the highly heterogeneous nature of OFCs and 
illustrate the utility of meta-analysis for discovering new genetic risk factors.
INTRODUCTION
Nonsyndromic orofacial clefts (OFCs) are among the most common human birth defects, 
occurring in 1 in 700 live births worldwide (Leslie and Marazita 2013). Nonsyndromic 
OFCs occur in the absence of other major cognitive or structural abnormalities, and have a 
complex etiology reflecting the combined actions of multiple genetic and environmental risk 
factors. The focus of much of the OFC genetics research has been on the most common 
forms: cleft lip with or without cleft palate (CL/P) and cleft palate alone (CP) (Dixon et al. 
2011; Leslie and Marazita 2013). Multiple successful genome-wide linkage and association 
studies have contributed to the substantial progress in identifying potentially causal genes 
for OFCs over the last ten years. To date, there have been eight CL/P GWASs (Beaty et al. 
2010; Birnbaum et al. 2009; Camargo et al. 2012; Grant et al. 2009; Leslie et al. 2016a; 
Mangold et al. 2010; Sun et al. 2015; Wolf et al. 2015), a genome-wide meta-analysis of two 
CL/P GWASs (Ludwig et al. 2012), and two GWASs of CP (Beaty et al. 2011; Leslie et al. 
2016b).
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Collectively, these studies have demonstrated that OFCs exhibit significant genetic 
heterogeneity. For CL/P, at least 20 different genetic loci have been identified with 
compelling statistical and biological support. In contrast, only two GWASs for CP have been 
published with mixed results. The first study, despite interrogating 400 CP case-parent trios, 
did not identify any statistically significant SNP main effects (Beaty et al. 2011). The second 
study identified a single locus associated with CP, but this association signal was limited to 
European populations because of very low frequencies of the risk allele in other populations 
(Leslie et al. 2016b; Mangold et al. 2016). For both CL/P and CP, the identified risk loci 
only account for a modest portion of the genetic variance of OFCs, suggesting that 
additional genetic risk factors may be involved. CL/P and CP have historically been 
considered distinct disorders due to the different developmental origins of the lip and palate 
(Jiang et al. 2006), different prevalence rates among males and females (Mossey and Little 
2002), and different proportions of syndromic cases (50% CP vs. 30% for CL/P) (Leslie and 
Marazita 2013). In the current study, we sought to identify additional genetic risk variants 
for OFCs, considering the historical groupings of CL/P and CP, but also exploring the 
possibility of shared etiology. Therefore, we conducted genome-wide meta-analyses for 
CL/P, CP, and all OFCs, drawing from the two largest CL/P studies published to date and the 
two published CP studies.
METHODS
Contributing GWAS studies
Two consortia contributed to this study (Table 1). The first, hereafter called GENEVA OFC, 
used a family-based design and included 1,604 case-parent trios with CL/P and 475 case-
parent trios with CP, respectively, from populations in Europe (Denmark and Norway), the 
United States, and Asia (Singapore, Taiwan, Philippines, Korea, and China). The specifics of 
this study were previously described in Beaty et al. (2010) and Beaty et al. (2011). Briefly, 
samples were genotyped for 589,945 SNPs on the Illumina Human610-Quadv.1_B 
BeadChip, genetic data were phased using SHAPEIT, and imputation was performed with 
IMPUTE2 software to the 1000 Genomes Phase 1 release (June 2011) reference panel. 
Genotype probabilities were converted to most-likely genotype calls with the GTOOL 
software (http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html).
The second consortium included samples contributing to the Pittsburgh Orofacial Cleft 
(POFC) study, comprising 823 cases and 1319 case-parent trios with CL/P, 78 cases and 165 
case-parent trios with CP, plus 1700 unaffected controls. Participants were recruited from 13 
countries in North America (United States), Central or South America (Guatemala, 
Argentina, Colombia, Puerto Rico), Asia (China, Philippines), Europe (Denmark, Turkey, 
Spain), and Africa (Ethiopia, Nigeria). Additional details on recruitment, genotyping, and 
quality controls are described in Leslie et al. (2016b) and Leslie et al. (2016a). Briefly, 
samples were genotyped for 539,473 SNPs on the Illumina HumanCore+Exome array. Data 
were phased with SHAPEIT2 and imputed using IMPUTE2 to the 1000 Genomes Phase 3 
release (September 2014) reference panel. The most-likely genotypes (i.e. genotypes with 
the highest probability [Q]) were selected for statistical analysis only if the genotype with 
the highest probability was greater than 0.5.
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A total of 412 individuals were in both the GENEVA OFC and POFC studies so we 
excluded these participants from the GENEVA OFC study for this analysis. Informed 
consent was obtained for all participants and all sites had both local IRB approval and 
approval at the University of Pittsburgh, the University of Iowa, or Johns Hopkins 
University.
SNP Selection
Quality control procedures were completed in each contributing study and have been 
described extensively in the original publications (Leslie et al. (2016b), Leslie et al. (2016a), 
Beaty et al. (2010) and Beaty et al. (2011)). In the POFC study, SNPs with minor allele 
frequencies (MAF) less than 1% or those deviating from Hardy-Weinberg Equilibrium 
(HWE p < 0.0001) in genetically-defined, unrelated European controls were excluded. 
Similarly, SNPs with MAF<1% or those deviating from HWE were excluded. To account for 
different marker sets and identifiers between the two imputed datasets, the final analysis 
included only those overlapping SNPs that were matched on chromosome, nucleotide 
position, and alleles. A total of 6,090,031 SNPs were included in the meta-analysis.
Statistical Analysis
We identified three analysis groups from the contributing studies: a case-control subgroup 
from POFC, an unrelated case-parent trio group from POFC, and an unrelated case-parent 
trio group from GENEVA OFC. In the case-control subgroup, logistic regression was used to 
test for association under the additive genetic model while including 18 principal 
components of ancestry (generated via principal component analysis [PCA] of 67,000 SNPs 
in low linkage disequilibrium across all ancestry groups) to adjust for population structure 
(Leslie et al. 2016a). The two case-parent trio subgroups from POFC and GENEVA were 
analyzed separately using the transmission disequilibrium test (TDT). The resulting effects 
estimates for the three analysis groups were combined in an inverse variance-weighted 
fixed-effects meta-analysis. The combined estimate, a weighted log odds ratio, follows a chi-
squared distribution with two degrees of freedom under the null hypothesis of no 
association. Heterogeneity of effects was examined using confidence intervals of the effect 
estimates. GWAS was performed for all cleft types combined and for the CL/P and CP 
groups separately.
Subpopulation Analyses
Because the contributing studies contained individuals from diverse populations, we also 
performed stratified analyses of Asian and European ancestry groups defined by PCA (Table 
1). We only considered the these subpopulations because they were the only ancestry groups 
represented in both OFC and GENEVA. In these analyses, 5 and 3 principal components of 
ancestry were included in European and Asian case-control analyses, respectively (Leslie et 
al. 2016a).
Bioinformatic Analysis of Top Hits
We performed functional annotation enrichment analysis on genes using ToppFun from the 
ToppGene Suite (Chen et al. 2009) and significance was assessed using Bonferroni adjusted 
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p-values. Enrichment of SNPs in regulatory regions was performed using FORGE v1.2 
(Dunham et al. 2014). Individual SNPs were annotated for potential regulatory function 
using HaploReg v4.1 (Ward and Kellis 2012, 2016).
RESULTS
CL/P
In the CL/P meta-analysis of 823 cases, 1700 controls, and 2811 trios, 1,248 SNPs from 
thirteen loci reached genome-wide significance (Table 2, Figure 1A). Of these, eleven loci 
have been reported previously, including 8q24, 1q32 (IRF6), and 17p13 (NTN1). The 15q24 
(ARID3B) locus, which reached genome-wide significance, was reported as a suggestive 
signal in the POFC study (Leslie et al. 2016a). We detected a novel association on 3q28 
(lead SNP rs76479869, p = 1.16 × 10−8) within the third intron of TP63 (Figure 2). Six 
additional loci approached genome-wide significance with p-values less than 5 × 10−7. Of 
these loci, 3q12.1 (COL8A1) was suggestive in the GENEVA OFC study, 5q13.1 (PIK3R1) 
and 17q21.32 (GOSR2/WNT9B) were suggestive in the POFC study. The remaining loci 
have not been associated with CL/P previously and include 4q21.1 (SHROOM3), 12q13.13 
(KRT18), and 8p12 (NRG1) (Supplemental Figures 1–3).
We also stratified our analyses by ancestral group to determine if there were stronger signals 
in these subgroups. Although we did not detect any new signals in these sub-group analyses, 
we did identify multiple genome-wide significant signals in each subgroup. In Europeans, 
we detected five genome-wide significant signals: 1p36 (PAX7), 8q21.3, 8q24, 17q23.2 
(TANC2), and 17p13 (NTN1) (Supplemental Figure 4A, Supplemental Table 1). In the 
subset with Asian ancestry, we detected three group specific signals: 1p22 (ARHGAP29), 
1q32 (IRF6), and 17p13 (NTN1) (Supplemental Figure 4B, Supplemental Table 2). In 
addition SNPs on 10q25 (VAX1) and 20q12 (MAFB) approached genome-wide 
significance. Overall, the stratified CL/P results are in agreement with previous findings 
(Beaty et al. 2010; Beaty et al. 2013; Leslie et al. 2015; Ludwig et al. 2012).
CP
The meta-analysis of CP included a total of 78 cases, 1700 controls, and 616 trios. We 
observed a single genome-wide significant hit previously identified on 1p36 in GRHL3 
(Figure 1B). The only other hit with a p-value less than 1 × 10−5 was on 5p13.2 within 
UGT3A2 (lead SNP rs604328, p = 5.85 × 10−6; Supplemental Figure 5). In the European 
subgroup, we identified two suggestive signals (see Supplemental Table 1): GRHL3, which 
we previously identified in Europeans (Leslie et al. 2016b), and a new hit on 11q22.2 (lead 
SNP rs2260433, p = 8.70 × 10−6; Supplemental Figure 6A). The Asian subgroup was 
limited to trios from the POFC and GENEVA OFC studies, so we performed a meta-analysis 
of just these two groups (272 total trios) using a one degree of freedom test. Although there 
were no genome-wide significant hits, three loci achieved p-values < 5 × 10−5, and these 
were driven by the GENEVA OFC trios (Supplemental Figure 6B). Specifically, markers on 
8q21.3, 8q24.3 (n.b. this is not the 8q24 peak in Europeans at 8q24.21), and 16p12.1 yielded 
suggestive evidence (Supplemental Table 2, Supplemental Figure 7–9).
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Historically, CL/P and CP have been analyzed separately. Nevertheless, we hypothesize that 
there may be genetic risk variants common to both sub-types, and therefore analysis of all 
OFCs (i.e., CL/P plus CP) may yield greater statistical power to identify such shared 
variants. Therefore, we used the above analytical approach to determine if combined 
analysis would identify new loci conferring risk to all OFCs. We identified 11 genome-wide 
significant loci (Figure 1C). Not surprisingly, all but one of these were genome-wide 
significant in the CL/P group, which was the largest contributing sample for this analysis. 
The remaining genome-wide significant signal was on 9q22, immediately downstream of 
FOXE1 (lead SNP rs12347191, p = 1.33 × 10−9; Figure 3). This locus was not genome-wide 
significant in either the CL/P (p = 7.75 × 10−7) or CP analyses (p = 5.42 × 10−4) alone, nor 
was it significant in either of the contributing studies.
In the all OFCs ancestry-specific subgroups, several previously reported associations were 
recapitulated. For example, in the European subgroup, the 17p13 (NTN1) and 8q24 loci 
reached genome-wide significance with 1p36 (PAX7) and 8q21.3 approaching genome-wide 
significance (Supplemental Table 1, Supplemental Figure 10A). In contrast, 1p22 
(ARHGAP29), 1q32 (IRF6), 10q25 (VAX1), 17p22 (NOG), and 20q12 (MAFB) showed 
genome-wide significant or suggestive p-values among Asians (Supplemental Table 2, 
Supplemental Figure 10B). The strengths of these signals in European and Asian 
populations are consistent with the results of previous studies. Novel signals with suggestive 
evidence of association were 6p24.3 (lead SNP rs1333657, p = 8.34 × 10−6; Supplemental 
Figure 11) in Europeans, and 9q33.3 (lead SNP rs78427461, p = 8.42 × 10−6; Supplemental 
Figure 12) in Asians.
Bioinformatics Analysis of Top Hits
To further explore the biological relevance of the associated loci, we subjected all genes in 
proximity to the top SNPs (± 100kb, N = 72 genes) to functional annotation enrichment 
analysis with ToppFun from the ToppGene Suite (Chen et al. 2009). These loci were 
enriched for genes expressed in the olfactory pit, olfactory placode, and non-floor plate 
epithelium identified by RNA-Seq in embryonic mouse tissues (E8.5-E10.5). Of the 17 
genes with this expression pattern, several are known OFC risk genes based on recognized 
Mendelian syndromes in humans and/or mouse models with craniofacial anomalies (e.g., 
IRF6, TP63, VAX1, and PAX7). However, this analysis can help prioritize candidate genes 
from associated loci otherwise lacking functional supporting evidence: NRG1, ZFHX4, 
KRT8, SHTN1, and FILIP1L.
Recognizing that OFC GWAS signals generally occur in non-coding parts of the genome, 
we also performed a FORGE analysis to look for tissue-specific signals using the Roadmap 
Epigenomics project data (Dunham et al. 2014). We did not detect any enrichment of 
signals, which likely reflects the multiple tissue types involved in craniofacial development, 
and the relative inaccessibility of the key tissue types. However, inspection of individual 
regions revealed several intriguing findings.
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The 3q28 association signal resides within the largest intron of TP63, specifically within an 
expanse of H3K27Ac and H3K4Me1 histone modifications in NHEK cells (normal human 
epidermal keratinocytes) (Figure 2A, B). Recently, Antonini et al. (2015) showed the 
orthologous region in mouse acts a cis-regulatory element that recapitulates p63 expression 
and is positively regulated by p63 (Figure 2B). We annotated all variants in strong linkage 
disequilibrium with rs76479869 for regulatory functions using HaploReg v4 (Figure 2C). 
Among the altered transcription factor motifs were multiple annotations for the Fox family 
of transcription factors, Pou transcription factors, and CEBPB. Most notable among these is 
SNP rs55660938 as the risk allele creates a binding site for CEBPB, a protein previously 
demonstrated to negatively regulate this enhancer (Antonini et al. 2015).
The 9q22 locus near FOXE1 was previously interrogated for craniofacial regulatory 
elements in zebrafish (Lidral et al. 2015) and mouse (Attanasio et al. 2013) (Figure 3B). 
Lidral et al. identified three regulatory elements at −82.4, −67.7, and +22.6 kb from the 
FOXE1 transcription start site that largely recapitulated endogenous FOXE1 expression in 
the oral epithelium, heart, and thyroid (Lidral et al. 2015). Independently, three additional 
elements downstream of FOXE1 showed activity in forebrain and facial mesenchyme of 
mouse embryos. Because these regulatory elements were already identified, we selected 
SNPs located within them for bioinformatics analysis (Figure 3C). Among the annotations, 
the risk allele at rs925487 destroys a PLAG1 binding site while the risk allele at rs10119853 
creates IRF binding sites.
DISCUSSION
We performed meta-analyses of two large GWAS to identify novel loci associated with risk 
to OFC. We identified new genome-wide significant loci for CL/P (3q28, TP63) and all 
OFCs (9q22, FOXE1), and recapitulated prior results for multiple loci. Overall, our results 
are in agreement with previous findings (Beaty et al. 2010; Leslie et al. 2016a; Leslie et al. 
2016b; Ludwig et al. 2016). Our stratified analyses in Europeans and Asians are consistent 
with our previous observations that stronger signals are found within the subpopulations 
with the most statistical power, reflecting the minor allele frequency and information content 
of SNPs in different populations (Murray et al. 2012).
TP63 is an essential regulator of epidermal morphogenesis. Dominant mutations clustered in 
TP63 cause six syndromes with overlapping phenotypic features: ectrodactyly-ectodermal 
dysplasia clefting syndrome (Celli et al. 1999), Hay-Wells syndrome (McGrath et al. 2001), 
Rapp-Hodgkin syndrome (Kantaputra et al. 2003), split-hand/foot malformation (Ianakiev et 
al. 2000), limb-mammary syndrome (van Bokhoven and Brunner 2002), and ADULT 
syndrome (Amiel et al. 2001). Affected individuals are variably affected with ectodermal 
dysplasia, orofacial clefting, and split-hand/foot malformation, among other features. The 
phenotypic spectrum may also include nonsyndromic clefts as a de novo mutation was 
previously reported in an individual with apparently nonsyndromic cleft lip and palate 
(Leoyklang et al. 2007). Deletion of p63 in mouse results in a similar constellation of defects 
(Yang et al. 1999).
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The complex regulation of TP63 expression occurs in a tissue and layer-specific manner and 
depends on two conserved modules within its intronic enhancer (Antonini et al. 2015). 
These modules positively regulate TP63 when bound by p63 protein but are negatively 
regulated by Cepba, Cebpb, and Pou3f1 transcription factors. Although there are no 
polymorphisms in the described p63 binding sites, our bioinformatics analysis showed the 
risk allele for rs55660938 creates a Cebpb binding site, suggesting misregulation of p63 
expression via this enhancer element contributes to development of orofacial clefts.
We identified an association between SNPs on 9q22 and OFCs by combining the CL/P and 
CP subtypes. This result follows several previous studies on this locus beginning with a 
genome-wide linkage scan with fine-mapping in CL/P that originally implicated FOXE1 
((Marazita et al. 2009)), followed by additional fine-mapping in CL/P and CP that narrowed 
the critical region further to a region near the FOXE1 gene (Moreno et al. 2009). More 
recently, an independent replication found that two of the top SNPs from previous studies 
were associated with CL/P, but were more strongly associated when CL/P and CP were 
analyzed together (Ludwig et al. 2014). Recessive FOXE1 mutations cause Bamforth-
Lazarus syndrome, a rare Mendelian disorder characterized by cleft palate and congenital 
hypothyroidism (Bamforth et al. 1989). Similarly, mice lacking Foxe1 have cleft palate and 
thyroid dysgenesis (De Felice et al. 1998). Despite the clear connection between OFCs and 
the FOXE1 gene, this locus has not been identified in any previous GWAS. Ludwig et al. 
(Ludwig et al. 2014) speculated that this may because the top SNPs from Moreno et al. 
(Moreno et al. 2009) are not well-represented on commercial SNP panels and previous 
candidate studies included only small numbers of SNPs. Therefore, our success may be due 
to dense genotyping in the region through custom SNP content and imputation of untyped 
SNPs. In addition, previous studies have not performed GWAS of all OFCs together. There 
is a growing emphasis on identifying subtype-specific association signals (e.g., CL or CLP), 
and we and others have contributed to that endeavor (Jia et al. 2015; Ludwig et al. 2016; 
Ludwig et al. 2012; Rahimov et al. 2008). However, this study also demonstrates that some 
signals reflect a shared etiology among the various cleft subtypes that will only be identified 
when all OFCs are considered together.
There are no common missense polymorphisms in FOXE1 and rare variants identified by 
sequencing do not account for the association signal, leading to a hypothesis that the 
functional variants are regulatory. Recently, multiple craniofacial enhancers were identified 
in a zebrafish screen of multi-species conserved elements or by ChIP-Seq of p300 in mouse 
craniofacial tissue. In the zebrafish study by Lidral et al. (Lidral et al. 2015), differential 
activity was observed for the −67.7kb element with alleles at rs7850258. The OFC risk allele 
creates MYC and ARNT binding sites that increase activity of the enhancer (Lidral et al. 
2015). In our study, rs7850258 was not among the top SNPs (p = 1.45 × 10−5) and is not in 
strong linkage disequilibrium with our lead SNP, rs12347191, (r2=0.33, D’=0.65 in 
Europeans, see Figure 3). We were unable to perform conditional analyses because of the 
large number of trios contributing to this study, so it remains possible SNP rs7850258 is an 
independent association signal, which would be consistent with the risk haplotypes 
described in Moreno et al. (Moreno et al. 2009). Our bioinformatic analysis of the other 
craniofacial enhancers identified several motifs altered by OFC risk alleles that are 
candidates for the molecular validation needed to identify specific functional variants 
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regulating FOXE1. A major contribution of this study is the dense genotyping of this region 
that could allow comprehensive interrogation of risk alleles for OFCs.
A number of loci approached genome-wide significance in the full CL/P GWAS. Most of 
these were suggestive in one of the contributing studies, but some were not observed 
previously, and included biologically relevant genes, SHROOM3 (4q21.1), keratins 
(12q13.13), and NRG1. SHROOM3 is an actin-binding protein required for neurulation. The 
12q13.13 locus contains a cluster of type II keratins, which heteropolymerize to form 
intermediate filaments in epithelial cells. The GWAS approach has now pointed to several 
genes involved in the cytoskeleton (Leslie et al. 2016a; Leslie et al. 2012). Additional 
molecular evidence on other OFC-related genes further supports regulation of cytoskeletal 
dynamics in the pathogenesis of OFCs (Biggs et al. 2014; Caddy et al. 2010; De Groote et 
al. 2015; Leslie et al. 2012). Similarly SHROOM3 and NRG1 join a list of genes, including 
GRHL3, IRF6, and TFAP2A, required for neurulation that are also implicated in OFCs 
(Copp and Greene 2013; Kousa et al. 2013; Wang et al. 2011).
In conclusion, we have performed a multi-ethnic genome-wide meta-analysis of CL/P, CP, 
and all OFCs combined which revealed two novel, biologically-relevant genes, TP63 (for 
CL/P) and FOXE1 (for all OFCs). Previously-reported associations were recapitulated, and 
several new suggestive loci were implicated. Overall, this study reinforces the notion that 
OFCs exhibit a high level of genetic heterogeneity and illustrates the utility of combining 
studies via meta-analysis to yield new discoveries. These findings contribute to our growing 
understanding of the genetic architecture of OFCs, and may one day benefit recurrence 
prediction and prognosis.
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Figure 1. Manhattan plots for genome-wide meta-analyses
(A) cleft lip with or without cleft palate (CL/P), (B) cleft palate (CP), (C) all orofacial clefts 
(CL/P plus CP). The red line denotes a Bonferroni-corrected genome-wide significant p-
value (p < 5 × 10−8). Peaks are labeled with the candidate gene or closest gene in the region; 
colored labels indicate the locus was identified in a previous study, black labels indicate new 
loci.
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Figure 2. SNPs in a TP63 enhancer are associated with CL/P
(A) LocusZoom plot of CL/P meta-analysis results. Points are color-coded based on linkage 
disequilbrium (r2) in Europeans. (B) Annotations for the depicted regions: chromatin state 
segmentation from ENCODE data in selected cell types, p63 ChIP-Seq and binding motifs 
from McDade et al. (2012), H3K27Ac and H3K4Meq from ENCODE. (C) Results from 
HaploReg analysis of SNPs in high linkage disequilibrium with lead SNP rs76479869.
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Figure 3. FOXE1 is associated with all OFCs
(A) LocusZoom plot for OFC meta-analysis results. Points are color coded based on linkage 
disequilbrium (r2) in Europeans. Labeled SNPs are denoted by diamonds: lead SNP 
rs12347191 and rs7850258, a functional SNP from Lidral et al. (2015). (B) Craniofacial 
enhancers in the region. In blue, enhancers tested in zebrafish from Lidral et al. (2015) study. 
In purple, enhances from the VISTA enhancer browser tested in mouse. (C) Results from 
HaploReg analysis of SNPs located in craniofacial enhancers.
Leslie et al. Page 17























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Hum Genet. Author manuscript; available in PMC 2018 March 01.
